Young Researchers Share Benefits of Global Scholar-in-Training Program
Four of the 2023 GSITA recipients explain how the program has benefited their careers.
Four of the 2023 GSITA recipients explain how the program has benefited their careers.
Dr. Edward Cliff presented a poster on the clinical benefit of cancer drugs granted accelerated approval.
Early-career scientists are the future of cancer research. Those who reach the postdoctoral level have already shown their extraordinary...
Each year, the American Association for Cancer Research (AACR) is proud to bring Associate Members to Washington, D.C., where...
Guest post by Jeremy Warner, MD, MS, and Deborah Doroshow, MD, PhD The world is facing a pandemic unlike...
Guest Post by Wafik S. El-Deiry, MD, PhD, FACP Fox Chase Cancer Center
The inaugural Cancer Disparities Progress Report, published today by the American Association for Cancer Research (AACR), highlights the urgent need...
The AACR Annual Meeting 2018 drew more than 22,600 people to Chicago, providing a front-row seat to some exciting...
Amidst an FDA investigation into secondary cancers after CAR T therapy, researchers show the risk is likely minimal.
The AACR supports the mission of World Cancer Day 2024 to Close the Care Gap, which it has worked...
Courtney Addison is eternally grateful for the CAR T-cell therapy that sent her son Cayden’s leukemia into remission. But...
The American Association for Cancer Research (AACR) applauds and commends President Obama and Vice President Biden for their dedication...
As February gives way to March, we bring you the latest round of editors’ picks selected by the editors...
Breast cancer researchers are packed up in San Antonio, eager to build on the latest information they gathered at...
Over the past decade, immune checkpoint inhibitors have transformed cancer care for a variety of tumor types. This form of immunotherapy can lead to long-lasting...
Studies featured at this year’s San Antonio Breast Cancer Symposium (SABCS) suggest that—in some situations—adjuvant radiotherapy may not be...
Earlier this week, the U.S. Food and Drug Administration (FDA) approved the molecularly targeted therapeutic niraparib (Zejula) for the...
For the month of August, the editors of the nine AACR journals have chosen to highlight results from two clinical...
Most breast cancers express the estrogen and/or progesterone hormone receptors, which fuel tumor growth upon engagement with their respective...
As the 15th AACR Conference on The Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved...
The rapid fire of U.S. Food and Drug Administration (FDA) approvals of new treatments for cancer continued last week...
The American Association for Cancer Research (AACR) publishes eight esteemed scientific journals. Each month, these journals feature a wide...
How the latest clinical therapies are helping patients and laboratory research informing future treatments.
As we welcome the fall season, it’s time for our September edition of Editors’ Picks, a monthly collection of...
The AACR Annual Meeting 2019 features the theme “Integrative Cancer Science • Global Impact • Individualized Patient Care.” That theme provided...
As recently as 10 years ago, the words “machine learning” evoked thoughts of sentient robots and fears of the...
As infections from SARS-CoV-2 began to rapidly spread across the United States in early 2020, many nonessential medical procedures, including cancer screenings, were...
Advances against cancer that make it to the clinic are a result of many years of hard work by...
The American Association for Cancer Research (AACR) is proud to offer Global Scholar-in-Training Awards (GSITA) to support the career...
On the heels of the U.S. Food and Drug Administration’s approval of a combination of immune checkpoint inhibitors for...